Multi-omics analysis of the lactylation-driven microenvironment and non-invasive clinical translation in hepatocellular carcinoma.
[BACKGROUND] Through integrated multi-omics strategy, this study aims to investigate the clinical value of a prognostic model derived from lysine lactylation (KLa) in hepatocellular carcinoma (HCC), t
APA
Gan X, Gao R, et al. (2026). Multi-omics analysis of the lactylation-driven microenvironment and non-invasive clinical translation in hepatocellular carcinoma.. Hepatology international, 20(2), 353-372. https://doi.org/10.1007/s12072-025-11016-w
MLA
Gan X, et al.. "Multi-omics analysis of the lactylation-driven microenvironment and non-invasive clinical translation in hepatocellular carcinoma.." Hepatology international, vol. 20, no. 2, 2026, pp. 353-372.
PMID
41699363
Abstract
[BACKGROUND] Through integrated multi-omics strategy, this study aims to investigate the clinical value of a prognostic model derived from lysine lactylation (KLa) in hepatocellular carcinoma (HCC), thereby promoting its clinical translation.
[METHODS] The key features for constructing lactylation-associated risk model were identified across the levels of KLa, protein and transcriptomic by integrating local cohort and public HCC cohorts. Immunohistochemistry and western blotting were performed to confirm the consistency between lactylation-associated risk and KLa modification level. Clinical and biological significance of lactylation-associated risk stratification was further characterized leveraging local cohort with public HCC cohort and single-cell sequencing. Finally, we explored the potential of ultrasound-based radiomics for non-invasive prediction of lactylation-associated risk.
[RESULTS] Lactylation-associated risk model effectively stratified HCC patients based on recurrence-free survival and identified individuals with early postoperative recurrence. High-risk patients demonstrated elevated KLa modification level and clinical characteristics indicative of poor prognosis: microvascular invasion, tumor thrombus, high Ki-67, advanced TNM and BCLC stages. At single-cell resolution, the predominantly immunosuppressive tumor immune microenvironment and KLa-driven proliferative tumor phenotype in high-risk patients elucidate the underlying biological mechanisms of HCC progression. The integration of ultrasound-based radiomics and clinical features demonstrated superior potential for lactylation-associated risk non-invasive prediction compared to single clinical model.
[CONCLUSION] Lactylation-associated risk model not only provides an effective assessment of recurrence risk in HCC patients but also mirrors the intratumoral KLa modification level, holding significant clinical and tumor biological relevance. Furthermore, the joint model integrating ultrasound-based radiomics and clinical features demonstrates potential for non-invasive prediction of lactylation-associated risk.
[METHODS] The key features for constructing lactylation-associated risk model were identified across the levels of KLa, protein and transcriptomic by integrating local cohort and public HCC cohorts. Immunohistochemistry and western blotting were performed to confirm the consistency between lactylation-associated risk and KLa modification level. Clinical and biological significance of lactylation-associated risk stratification was further characterized leveraging local cohort with public HCC cohort and single-cell sequencing. Finally, we explored the potential of ultrasound-based radiomics for non-invasive prediction of lactylation-associated risk.
[RESULTS] Lactylation-associated risk model effectively stratified HCC patients based on recurrence-free survival and identified individuals with early postoperative recurrence. High-risk patients demonstrated elevated KLa modification level and clinical characteristics indicative of poor prognosis: microvascular invasion, tumor thrombus, high Ki-67, advanced TNM and BCLC stages. At single-cell resolution, the predominantly immunosuppressive tumor immune microenvironment and KLa-driven proliferative tumor phenotype in high-risk patients elucidate the underlying biological mechanisms of HCC progression. The integration of ultrasound-based radiomics and clinical features demonstrated superior potential for lactylation-associated risk non-invasive prediction compared to single clinical model.
[CONCLUSION] Lactylation-associated risk model not only provides an effective assessment of recurrence risk in HCC patients but also mirrors the intratumoral KLa modification level, holding significant clinical and tumor biological relevance. Furthermore, the joint model integrating ultrasound-based radiomics and clinical features demonstrates potential for non-invasive prediction of lactylation-associated risk.
MeSH Terms
Humans; Carcinoma, Hepatocellular; Liver Neoplasms; Tumor Microenvironment; Male; Female; Middle Aged; Prognosis; Multiomics
같은 제1저자의 인용 많은 논문 (5)
- Chimeric antigen receptor T-cell therapy for relapsed/refractory primary cutaneous B-lymphoblastic lymphoma with rapid and durable systemic regression.
- Evidence for the Monitoring of Minimal Residual Disease Dynamics to Guide Clinical Practice in Patients with Multiple Myeloma.
- An interpretable machine learning model for predicting visceral pleural invasion in cT1 lung adenocarcinoma based on habitat analysis.
- Comprehensive evaluation of tumor response better evaluates the efficacy of neoadjuvant chemotherapy and predicts the prognosis in gastric cancer - a post hoc analysis of a single-center randomized controlled trial.
- Design, synthesis, and evaluation of cyclic C7-bridged monocarbonyl curcumin analogs containing an -methoxy phenyl group as potential agents against gastric cancer.